A股異動 | 天康生物午後拉漲近9% 暫五連升累漲逾36%
格隆匯10月30日丨天康生物(002100.SZ)午後拉昇,暫五日連升累漲逾36%。現報13.79元,漲8.93%,暫成交10.6億元,最新總市值139.6億元。業內表示,近期豬肉價格大漲,養殖盈利水平高,養殖户補欄復養熱情高。9月份生豬存欄環比增長0.6%,能繁母豬環比增長3.7%,已經止跌回升,農業農村部預計明年有望基本恢復到正常水平。生豬存欄量逐步恢復,飼料需求逐步擴大。根據2018年年報,在天康生物的主營業務中,飼料的比例位列第一,佔比約為48.59%。此外,公司上週五(25日)晚間公告稱,前三季度純利同比增長16.35%至3.02億元,績後獲華泰證券、太平洋證券等多家機構予“買入”評級,天康生物亦於本週一(28日)早盤漲停。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.